KING OF PRUSSIA, PA — Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.
News
- CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant ...
- Escient Pharmaceuticals Announces Oral Presentation of Data Highlighting the Preclinical ...
... program at the American Academy of Allergy, Asthma and Immunology Annual meeting being held in San Antonio, TX, February 24-27, 2023.
- CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with ... - Yahoo Finance
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today presented results ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.
- CSL's Phase 3 Study Shows Firs - GuruFocus.com
26, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.
- FDA authorizes the first at-home test for COVID-19 and the flu | TPR - Texas Public Radio
Bioscience-Medicine COVID-19fluTop Stories ... Vigil in downtown San Antonio marks one year of Russian invasion of Ukraine.